Literature DB >> 31988173

Gastrointestinal Coinfection Promotes Chlamydial Pathogenicity in the Genital Tract.

Qi Tian1,2, Zengzi Zhou1,2, Luying Wang1,2, Al-Mutassim Hani Abu-Khdeir2, Zhi Huo2,3, Xin Sun1,2, Nu Zhang2, Robert Schenken4, Yufeng Wang5, Min Xue6, Guangming Zhong7.   

Abstract

Sexually transmitted Chlamydia, which can cause fibrotic pathology in women's genital tracts, is also frequently detected in the gastrointestinal tract. However, the medical significance of the gastrointestinal Chlamydia remains unclear. A murine Chlamydia readily spreads from the mouse genital tract to the gastrointestinal tract while inducing oviduct fibrotic blockage or hydrosalpinx. We previously proposed a two-hit model in which the mouse gastrointestinal Chlamydia might induce the second hit to promote genital tract pathology, and we are now providing experimental evidence for testing the hypothesis. First, chlamydial mutants that are attenuated in inducing hydrosalpinx in the genital tract also reduce their colonization in the gastrointestinal tract, leading to a better correlation of chlamydial induction of hydrosalpinx with chlamydial colonization in the gastrointestinal tract than in the genital tract. Second, intragastric coinoculation with a wild-type Chlamydia rescued an attenuated Chlamydia mutant to induce hydrosalpinx, while the chlamydial mutant infection in the genital tract alone was unable to induce any significant hydrosalpinx. Finally, the coinoculated gastrointestinal Chlamydia failed to directly spread to the genital tract lumen, suggesting that gastrointestinal Chlamydia may promote genital pathology via an indirect mechanism. Thus, we have demonstrated a significant role of gastrointestinal Chlamydia in promoting pathology in the genital tract possibly via an indirect mechanism. This study provides a novel direction/dimension for further investigating chlamydial pathogenic mechanisms.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Chlamydiazzm321990; gastrointestinal colonization; genital pathology; gut chlamydia; hydrosalpinx; pathogenesis; tubal fibrosis

Mesh:

Year:  2020        PMID: 31988173      PMCID: PMC7093119          DOI: 10.1128/IAI.00905-19

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  60 in total

1.  Prevalence and characteristics of rectal chlamydia and gonorrhea cases among men who have sex with men after the introduction of nucleic acid amplification test screening at 2 Canadian sexually transmitted infection clinics.

Authors:  Jennifer Gratrix; Ameeta E Singh; Joshua Bergman; Cari Egan; Justin McGinnis; Steven J Drews; Ron Read
Journal:  Sex Transm Dis       Date:  2014-10       Impact factor: 2.830

2.  Genome-wide identification of Chlamydia trachomatis antigens associated with tubal factor infertility.

Authors:  Allison K Rodgers; Nicole M Budrys; Siqi Gong; Jie Wang; Alan Holden; Robert S Schenken; Guangming Zhong
Journal:  Fertil Steril       Date:  2011-07-13       Impact factor: 7.329

3.  Chlamydia trachomatis antigens recognized in women with tubal factor infertility, normal fertility, and acute infection.

Authors:  Nicole M Budrys; Siqi Gong; Allison K Rodgers; Jie Wang; Christopher Louden; Rochelle Shain; Robert S Schenken; Guangming Zhong
Journal:  Obstet Gynecol       Date:  2012-05       Impact factor: 7.661

4.  VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells.

Authors:  Georg Stary; Andrew Olive; Aleksandar F Radovic-Moreno; David Gondek; David Alvarez; Pamela A Basto; Mario Perro; Vladimir D Vrbanac; Andrew M Tager; Jinjun Shi; Jeremy A Yethon; Omid C Farokhzad; Robert Langer; Michael N Starnbach; Ulrich H von Andrian
Journal:  Science       Date:  2015-06-19       Impact factor: 47.728

5.  Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease.

Authors:  Catherine M O'Connell; Robin R Ingalls; Charles W Andrews; Amy M Scurlock; Toni Darville
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

6.  Chlamydial infection of the gastrointestinal tract: a reservoir for persistent infection.

Authors:  Laxmi Yeruva; Nicole Spencer; Anne K Bowlin; Yin Wang; Roger G Rank
Journal:  Pathog Dis       Date:  2013-07-10       Impact factor: 3.166

7.  Interleukin-13 promotes susceptibility to chlamydial infection of the respiratory and genital tracts.

Authors:  Kelly L Asquith; Jay C Horvat; Gerard E Kaiko; Alison J Carey; Kenneth W Beagley; Philip M Hansbro; Paul S Foster
Journal:  PLoS Pathog       Date:  2011-05-05       Impact factor: 6.823

8.  Is it time to switch to doxycycline from azithromycin for treating genital chlamydial infections in women? Modelling the impact of autoinoculation from the gastrointestinal tract to the genital tract.

Authors:  Andrew P Craig; Fabian Y S Kong; Laxmi Yeruva; Jane S Hocking; Roger G Rank; David P Wilson; Basil Donovan
Journal:  BMC Infect Dis       Date:  2015-04-30       Impact factor: 3.090

9.  Oviduct infection and hydrosalpinx in DBA1/j mice is induced by intracervical but not intravaginal inoculation with Chlamydia muridarum.

Authors:  Lingli Tang; Hongbo Zhang; Lei Lei; Siqi Gong; Zhiguang Zhou; Joel Baseman; Guangming Zhong
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

10.  Chlamydial induction of hydrosalpinx in 11 strains of mice reveals multiple host mechanisms for preventing upper genital tract pathology.

Authors:  Jianlin Chen; Hongbo Zhang; Zhou Zhou; Zhangsheng Yang; Yiling Ding; Zhiguang Zhou; Edward Zhong; Bernard Arulanandam; Joel Baseman; Guangming Zhong
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

View more
  9 in total

1.  Lactobacillus Modulates Chlamydia Infectivity and Genital Tract Pathology in vitro and in vivo.

Authors:  Hongliang Chen; Shuling Min; Li Wang; Lanhua Zhao; Fangzhen Luo; Wenbo Lei; Yating Wen; Lipei Luo; Qianting Zhou; Lixiu Peng; Zhongyu Li
Journal:  Front Microbiol       Date:  2022-04-28       Impact factor: 6.064

2.  Effects of Immunomodulatory Drug Fingolimod (FTY720) on Chlamydia Dissemination and Pathogenesis.

Authors:  Zengzi Zhou; Lingxiang Xie; Luying Wang; Min Xue; Dabao Xu; Guangming Zhong
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

3.  Chlamydia Spreads to the Large Intestine Lumen via Multiple Pathways.

Authors:  Zengzi Zhou; Qi Tian; Luying Wang; Min Xue; Dabao Xu; Guangming Zhong
Journal:  Infect Immun       Date:  2021-07-19       Impact factor: 3.441

Review 4.  Chlamydia overcomes multiple gastrointestinal barriers to achieve long-lasting colonization.

Authors:  Guangming Zhong
Journal:  Trends Microbiol       Date:  2021-04-14       Impact factor: 17.079

Review 5.  Immunopathogenesis of genital Chlamydia infection: insights from mouse models.

Authors:  Jacob Dockterman; Jörn Coers
Journal:  Pathog Dis       Date:  2021-03-31       Impact factor: 3.951

6.  Chlamydia Deficient in Plasmid-Encoded Glycoprotein 3 (pGP3) as an Attenuated Live Oral Vaccine.

Authors:  Zengzi Zhou; Qi Tian; Luying Wang; Guangming Zhong
Journal:  Infect Immun       Date:  2022-01-31       Impact factor: 3.609

7.  Characterization of Pathogenic CD8+ T cells in Chlamydia-Infected OT1 Mice.

Authors:  Zengzi Zhou; Qi Tian; Luying Wang; Xin Sun; Nu Zhang; Min Xue; Dabao Xu; Guangming Zhong
Journal:  Infect Immun       Date:  2021-11-01       Impact factor: 3.609

Review 8.  Innate Lymphoid Cells in Response to Intracellular Pathogens: Protection Versus Immunopathology.

Authors:  Anna A Korchagina; Ekaterina Koroleva; Alexei V Tumanov
Journal:  Front Cell Infect Microbiol       Date:  2021-12-06       Impact factor: 5.293

9.  Gastrointestinal Chlamydia-Induced CD8+ T Cells Promote Chlamydial Pathogenicity in the Female Upper Genital Tract.

Authors:  Qi Tian; Zengzi Zhou; Luying Wang; Xin Sun; Bernard Arulanandam; Dabao Xu; Min Xue; Guangming Zhong
Journal:  Infect Immun       Date:  2021-07-06       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.